CEO of Cell Therapeutics Inc. (CTIC, Financial) James A Bianco sells 500,000 shares of CTIC on 06/30/2010 at an average price of $0.37 a share.
Cell Therapeutics Inc. has a market cap of $279.2 million; its shares were traded at around $0.4238 with and P/S ratio of 3489.6.
Cell Therapeutics Inc. has a market cap of $279.2 million; its shares were traded at around $0.4238 with and P/S ratio of 3489.6.
Directors and Officers Recent Trades:
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 05/28/2010 at the average price of 0.39. Phillip M Phd Nudelman owns at least 1,076,306 shares after this. The price of the stock has increased by 8.67% since.
- Sell: Director Richard L Love sold 11,300 shares of CTIC stock on 05/24/2010 at the average price of 0.38. Richard L Love owns at least 1,436,112 shares after this. The price of the stock has increased by 11.53% since.
- Sell: Director Richard L Love sold 63,700 shares of CTIC stock on 05/24/2010 at the average price of 0.35. Richard L Love owns at least 1,447,412 shares after this. The price of the stock has increased by 21.09% since.
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 05/03/2010 at the average price of 0.6. Phillip M Phd Nudelman owns at least 1,116,306 shares after this. The price of the stock has decreased by 29.37% since.
